Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy
- 31 August 2016
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 283, 213-223
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in NeuronsCell, 2013
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- α-Synuclein and Neuronal Cell DeathMolecular Neurobiology, 2012
- Alpha-synuclein: from secretion to dysfunction and deathCell Death & Disease, 2012
- Adenosine A2A receptor gene disruption protects in an α‐synuclein model of Parkinson's diseaseAnnals of Neurology, 2011
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic interventionNeurobiology of Disease, 2010
- Adenosine signaling and function in glial cellsCell Death & Differentiation, 2009
- Molecular mechanisms of α-synuclein neurodegenerationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockadePurinergic Signalling, 2005
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003